Futraful therapy on liver cancer.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000188:drug therapy / Q000473:pathology; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives*; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008113:Liver Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D008937:Mitomycins / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D012075:Remission, Spontaneous; D013488:Suppositories; D005641:Tegafur / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D008937:Mitomycins; D013488:Suppositories; D005641:Tegafur; D007770:L-Lactate Dehydrogenase; D000469:Alkaline Phosphatase; D005472:Fluorouracil